Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

THC Biomed Intl Ltd C.THC

Alternate Symbol(s):  THCBF

THC Biomed Intl Ltd. is a Canada-based cannabis producer. The Company’s principal business is the production and sale of cannabis through THC BioMed Ltd., which is a small batch Licensed Producer as regulated by the Cannabis Act which regulates the production, distribution, and possession of cannabis for both medical and adult recreational access in Canada. The Company’s biological assets consist of cannabis plants (mother plants and clones for growth); resin; oil; harvested marijuana flowers prior to completion of the drying, grading and testing processes; and edible concentrate. The Company operates in a single reportable segment being the cultivation and sale of cannabis. Its subsidiaries include THC BioMed Ltd., Clone Shipper Ltd., THC BioMed Victoria Falls Ltd., THC2GO Dispensaries Ltd. (THC2GO), and THC BioMed Lesotho Ltd. (THC Lesotho). Clone Shipper Ltd. owns all rights to the Clone Shipper product used to transport live plants.


CSE:THC - Post by User

Bullboard Posts
Comment by luther30on Jan 12, 2017 12:09pm
98 Views
Post# 25699648

RE:RE:RE:RE:RE:RE:RE:RE:RE:Market makers are not interested

RE:RE:RE:RE:RE:RE:RE:RE:RE:Market makers are not interested Hey Investorman, how do you come up with 150M for THC in much smaller facility than CGC who is reporting 8M?



Iinvestorman wrote: They're not only gong to corner the homegrowing market. They're also going to supply the other marijauna producers with clones. In a legalised market, that'll be $100 to $200 million in sales.

Their R&D will be extremely valuable as they discover and patent cannabis based remedies for several ailments. That will be worth hundreds of millions to billions.

Even if R&D fails, they also have 29 strains of cannabis and extracts that they will be wholeselling will also be profitable, $50 to $70 million in sales based on THC's current squarefootage. Due to market demands in the future legalised market, I believe that they will have to expand their facility. This company will be doing at least $150 million in sales every year. Marijuana is currently a $9 billion industry, projected to becoming $22.5 billion during legalisation. $150 million is a very small share of the market, that is not projecting further what they have currently planned for. They could go into marijuana retail, which could easily double their sales figures. They could expand their facilities or aquire other facilities. But at only $150 million in sales, the shares will be worth $25. \

That's why people like me are holding on THC for a while.




Bullboard Posts